单根左颈总动脉烟囱支架联合Castor单分支支架移植物腔内修复治疗主动脉2区区域病变的疗效
该单中心回顾性队列研究纳入2021年6月至2022年4月收治的20例主动脉2区病变患者,均接受左颈总动脉烟囱支架联合Castor单分支支架移植物的SC-TEVAR治疗。6个月随访显示分支动脉通畅率100%、技术成功率90%,无死亡、卒中、内漏等并发症。作者认为SC-TEVAR可能是一种相对简单、安全、有效的新治疗方法。
要点
- SC-TEVAR联合左颈总动脉烟囱支架与Castor单分支支架治疗主动脉2区病变。
- 6个月随访分支动脉通畅率100%,技术成功率90%,无死亡及严重并发症。
- 仅1例出现腹股沟伤口血肿,经保守治疗处理。
核心结论
- SC-TEVAR似乎是一种相对简单、安全、有效的治疗主动脉2区病变的新方法。
- 作者认为SC-TEVAR在本回顾性研究中显示了满意结果,可作为一种简便方法推广用于治疗主动脉2区病变。
研究设计与样本
- 单中心回顾性队列研究,纳入2021年6月至2022年4月收治的20例主动脉2区病变患者。
- 病变包括直径≥5.0 cm的真性主动脉退行性动脉瘤和深度>1.0 cm或基底宽度>2.0 cm的穿透性主动脉溃疡。
- 所有20例患者均接受SC-TEVAR治疗,即左颈总动脉烟囱支架联合Castor单分支支架移植物。
- 收集基线数据和术中数据以评估该方法的安全性和有效性。
- 术后1个月和6个月评估目标血管通畅性和相关并发症。
主要发现
- 6个月随访时无心脏事件、卒中、偏瘫、I型内漏、II型内漏、近端支架移植物诱导的新发破口、远端支架移植物诱导的新发破口、伤口感染或出血。
- 仅1例患者出现腹股沟伤口血肿并接受保守治疗。
- 无患者发生左颈总动脉或左锁骨下动脉狭窄或闭塞,分支动脉通畅率为100%。
- 技术成功率为90%。
临床怎么用
- 作者认为SC-TEVAR可作为一种简便方法推广用于治疗主动脉2区病变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To observe the short-term efficacy of thoracic endovascular aortic repair (TEVAR) using a single left common carotid artery chimney stent combined with a Castor single-branched stent-graft (SC-TEVAR) in the treatment of zone 2 (Z2) aortic diseases. MATERIALS AND METHODS: To conduct a retrospective analysis of 20 patients with Z2 aortic diseases who were treated in our department from June 2021 to April 2022. The lesions included true aortic degenerative aneurysms with diameter ≥5.0 cm and penetrating aortic ulcers with depth >1.0 cm or basal width >2.0 cm. All 20 patients accepted the SC-TEVAR treatment, which was a new hybrid method to assure the flow of the left common carotid artery (LCCA) and left subclavian artery (LSA). This method was defined as a concomitant chimney stent for LCCA and a Castor single-branched stent graft for the aorta and LSA. The baseline data and intraoperative data were collected to evaluate the safety and efficacy of this method. The patency of the target blood vessel and any associated complications were evaluated at 1 and 6 months postoperatively, to analyze the safety and efficacy of this new method. RESULTS: After discharge from the hospital, all patients were followed up by a specific follow-up team. At 6 monthly follow-up period, there were no cardiac events, stroke, hemiplegia, type I endoleak, type II endoleak, proximal stent graft-induced new entries, distal stent graft-induced new entries, wound infection, or bleeding. Only 1 patient developed an inguinal wound hematoma and got conservative treatment. Importantly, no patients developed stenosis or occlusion of the LCCA or LSA. The patency of branched arteries was 100%. The technical success rate was 90%. CONCLUSION: SC-TEVAR appears to be a new and relatively simple, safe, and effective treatment for Z2 aortic diseases.Clinical ImpactThis was a single-center retrospective cohort study. A total of 20 patients with zone 2 aortic diseases accepted a new hybrid surgical method named SC-TEVAR. This method was not complicated and could be finished with only 3 peripheral artery exposure. The result showed no mortality, 100% patency of the branch artery, and 90% of technical success in 6 months of follow-up time. SC-TEVAR showed a satisfactory result in this retrospective study and could be promoted as an easy method to treat zone 2 aortic diseases.
引用
- Fang J, Tian C, Chen D, et al. Efficacy of Endovascular Repair Using Single Left Common Carotid Artery Stent Combined with Castor Single-Branched Stent-Graft in the Treatment of Regional Diseases of Zone 2 of the Aorta. J Endovasc Ther. 2024. PMID: 38284343. doi:10.1177/15266028231224249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。